Antibiotics and Breast Cancer - What's the Meaning of This?

JAMA

Volumn 291, Issue 7, 2004, Pages 880-881

  Ness, Roberta B ^a   Cauley, Jane A ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ANTIBIOTIC AGENT; CYCLOOXYGENASE 2; ENTEROLACTONE; ESTROGEN; GELATINASE B; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHYTOESTROGEN; PROSTAGLANDIN E2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SULFATRIMETHOPRIM; TETRACYCLINE; VASCULOTROPIN; ANTIINFECTIVE AGENT;

ACNE; AGE; ALCOHOL CONSUMPTION; ANTIBIOTIC THERAPY; APOPTOSIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; EDITORIAL; FAMILY HISTORY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; OBESITY; PARITY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; ROSACEA; SOCIAL CLASS; BREAST TUMOR; INFECTION; INFLAMMATION; NOTE; RISK;

ANTI-BACTERIAL AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; INFECTION; INFLAMMATION; RISK;

EID: 1442285093     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.7.880     Document Type: Editorial

References (21)

1. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA. 2004;291:827-835.
2. Psaty BM, Koepsell TD, Lin D, et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc. 1999;47:749-754.
3. Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst. 1998;90:455-460.
4. Kundu N, Yang Q, Dorsey R, Fulton AM. Increased cyclooxygenase-2 (COX-2) expression and activity in a murine model of metastatic breast cancer. Int J Cancer. 2001;93:681-686.
5. Cauley JA, Zmuda JM, Lui L-Y, et al. Lipid-lowering drug use and breast cancer in older women: a prospective study. J Womens Health (Larchmt). 2003;12:749-756.
6. Ianaro, A, Ialenti A, Maffia P, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Clin Ther. 2000;292:156-163.
7. Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonon P, Adlercreutz H. Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol. 2002;155:472-477.
8. Nord CE, Edfund C. Impact of antimicrobial agents on human intestinal microflora. J Chemother. 1990;2:218-237.
9. Ames BN, Gold LS, Wilett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A. 1995;92:5258-5265.
10. Steele VE, Moon RC, Lubet RA, et al. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models methods and results from the NCI drug chemoprevention drug development program. J Cell Biol. 1994;20:32-53.
11. Harris RE, Chlebowski RT, Jackson RD, et al. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 2003;63:6096-6101.
12. O'Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer. 2001;85:473-483.
13. Christensen S, Hagen TM, Shigenaga MK, Ames BN. Chronic inflammation, mutation, and cancer. In: Parsonnet J, ed. Microbes and Malignancy: Infection as a Cause of Human Cancers. New York, NY: Oxford University Press; 1999:35-88.
14. Reed MJ, Purohit A. Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocrine Rev. 1997;18:701-715.
15. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2002;95:1218-1226.
16. Edwards JG, Abrams KR, Leverment JN, et al. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax. 2000;55:731-735.
17. Badawi AF, Mostafa MH, Probert A, O'Connor PJ. Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev. 1995;4:45-59.
18. Williams MP, Pounder RE. Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol. 1999;94:511-516.
19. Monson RR, Yen S, MacMahon B. Chronic mastitis and carcinoma of the breast. Lancet. 1976;2:224-226.
20. Cibere J, Sibley J, Haga M. Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum. 1997;40:1580-1586.
21. Bamford JT. Rosacea: current thoughts on origin. Semin Cutan Med Surg. 2001;20:199-206.